Immediate versus delayed zoledronic acid for prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen-N03CC

Breast Cancer Research and Treatment ◽

10.1007/s10549-009-0332-2 ◽

2009 ◽

Vol 117 (3) ◽

pp. 603-609 ◽

Author(s):

Stephanie L. Hines ◽

Betty Mincey ◽

Todor Dentchev ◽

Jeff A. Sloan ◽

Edith A. Perez ◽

...

Keyword(s):

Breast Cancer ◽

Zoledronic Acid ◽

Bone Loss ◽

Postmenopausal Women ◽

Prevention Of Bone Loss

Download Full-text

5201 POSTER The EXpand Study – Effect of Zoledronic Acid on Prevention of Bone Loss, During Extended Adjuvant Therapy With Letrozole in Postmenopausal Women With Primary Hormone Receptor Positive Breast Cancer Compared to Letrozole Alone

European Journal of Cancer ◽

10.1016/s0959-8049(11)71643-4 ◽

2011 ◽

Vol 47 ◽

pp. S390 ◽

Author(s):

M. Hellrieqel ◽

M. Mueller ◽

T. Reimer ◽

D.T. Baerens ◽

A. von der Assen ◽

...

Keyword(s):

Breast Cancer ◽

Zoledronic Acid ◽

Bone Loss ◽

Adjuvant Therapy ◽

Postmenopausal Women ◽

Hormone Receptor ◽

Hormone Receptor Positive ◽

Prevention Of Bone Loss ◽

Extended Adjuvant Therapy ◽

Positive Breast Cancer

Download Full-text

5-year follow-up of a randomized controlled trial of immediate versus delayed zoledronic acid for the prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen: N03CC (Alliance) trial

Cancer ◽

10.1002/cncr.29327 ◽

2015 ◽

Vol 121 (15) ◽

pp. 2537-2543 ◽

Author(s):

Nina D. Wagner-Johnston ◽

Jeff A. Sloan ◽

Heshan Liu ◽

Ann E. Kearns ◽

Stephanie L. Hines ◽

...

Keyword(s):

Breast Cancer ◽

Randomized Controlled Trial ◽

Zoledronic Acid ◽

Bone Loss ◽

Postmenopausal Women ◽

Controlled Trial ◽

Randomized Controlled ◽

Prevention Of Bone Loss

Download Full-text

Erratum to: Guidance for the prevention of bone loss and fractures in postmenopausal women treated with aromatase inhibitors for breast cancer: an ESCEO position paper

Osteoporosis International ◽

10.1007/s00198-012-1930-0 ◽

2012 ◽

Vol 23 (11) ◽

pp. 2577-2577 ◽

Author(s):

R. Rizzoli ◽

◽

J. J. Body ◽

A. DeCensi ◽

J. Y. Reginster ◽

...

Keyword(s):

Breast Cancer ◽

Bone Loss ◽

Postmenopausal Women ◽

Aromatase Inhibitors ◽

Position Paper ◽

Prevention Of Bone Loss

Download Full-text

2008 POSTER The E-ZO-FAST trial: Zoledronic acid (ZA) effectively inhibits aromatase inhibitor associated bone loss (AIBL) in postmenopausal women (PMW) with early breast cancer (EBC) receiving adjuvant Letrozole (Let)

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(07)70770-x ◽

2007 ◽

Vol 5 (4) ◽

pp. 186-187 ◽

Author(s):

N. Schenk ◽

A. Lombart ◽

A. Frassoladti ◽

P. Neven ◽

G. Jerusalem ◽

...

Keyword(s):

Breast Cancer ◽

Zoledronic Acid ◽

Bone Loss ◽

Aromatase Inhibitor ◽

Postmenopausal Women ◽

Early Breast Cancer

Download Full-text

The effect of zoledronic acid on aromatase inhibitor associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole: 36 months follow-up of ZO-FAST.

10.1158/0008-5472.sabcs-44 ◽

2009 ◽

Author(s):

H Eidtmann ◽

NJ Bundred ◽

R DeBoer ◽

A Llombart ◽

N Davidson ◽

...

Keyword(s):

Breast Cancer ◽

Zoledronic Acid ◽

Bone Loss ◽

Aromatase Inhibitor ◽

Postmenopausal Women ◽

Early Breast Cancer

Download Full-text

The Effect of Zoledronic Acid on Aromatase Inhibitor-Associated Bone Loss in Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Letrozole: The Z-FAST Study 5-Year Final Follow-Up.

10.1158/0008-5472.sabcs-09-4083 ◽

2009 ◽

Author(s):

A. Brufsky ◽

G. Harker ◽

J. Beck ◽

R. Carroll ◽

L. Jin ◽

...

Keyword(s):

Breast Cancer ◽

Zoledronic Acid ◽

Bone Loss ◽

Aromatase Inhibitor ◽

Postmenopausal Women ◽

Early Breast Cancer

Download Full-text

Zoledronic acid (ZA) effectively inhibits cancer treatment-induced bone loss (CTIBL) in postmenopausal women (PMW) with early breast cancer (BCa) receiving adjuvant letrozole (Let): 12 mos BMD results of the Z-FAST trial

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.533 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 533-533 ◽

Author(s):

A. Brufsky ◽

W. G. Harker ◽

J. T. Beck ◽

R. Carroll ◽

E. Tan-Chiu ◽

...

Keyword(s):

Breast Cancer ◽

Zoledronic Acid ◽

Bone Loss ◽

Cancer Treatment ◽

Postmenopausal Women ◽

Early Breast Cancer

Download Full-text

Zoledronic acid (ZA) prevents aromatase inhibitor (Al)-associated bone loss in postmenopausal women with early breast cancer -36-month follow-up of the Z-FAST study

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(08)70810-3 ◽

2008 ◽

Vol 6 (7) ◽

pp. 197 ◽

Author(s):

A. Brufskv ◽

L. Bosserman ◽

R. Caradonna ◽

B. Haley ◽

M. Jones ◽

...

Keyword(s):

Breast Cancer ◽

Zoledronic Acid ◽

Bone Loss ◽

Aromatase Inhibitor ◽

Postmenopausal Women ◽

Early Breast Cancer

Download Full-text

P153 An integrated analysis of zoledronic acid (ZA) for prevention of aromatase inhibitor associated bone loss (AIBL) in postmenopausal women (PMW) with early breast cancer (BCa) receiving adjuvant letrozole (LET)

10.1016/s0960-9776(07)70213-8 ◽

2007 ◽

Vol 16 ◽

pp. S57 ◽

Author(s):

A. Brufsky ◽

N. Bundred ◽

R. Coleman ◽

R. Lambert-Falls ◽

R. Mena ◽

...

Keyword(s):

Breast Cancer ◽

Zoledronic Acid ◽

Bone Loss ◽

Aromatase Inhibitor ◽

Postmenopausal Women ◽

Early Breast Cancer ◽

Integrated Analysis

Download Full-text

P154 Twenty-four month follow-up of the effect of zoledronic acid (ZA) on aromatase inhibitor associated bone loss (AIBL) in postmenopausal women (PMW) with early breast cancer (BCa) receiving adjuvant letrozole (LET)

10.1016/s0960-9776(07)70214-x ◽

2007 ◽

Vol 16 ◽

pp. S57 ◽

Author(s):

A. Brufsky ◽

K. Lund ◽

S. Papish ◽

P. Cobb ◽

P. Eisenberg ◽

...

Keyword(s):

Breast Cancer ◽

Zoledronic Acid ◽

Bone Loss ◽

Aromatase Inhibitor ◽

Postmenopausal Women ◽

Early Breast Cancer

Download Full-text